Recombinant human albumin (Anruite Biotech)
重组人白蛋白（安睿特生物）
Report date: 2026/03/25 09:58:50
Base Information
Drug NameRecombinant human albumin (Anruite Biotech)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2024/04/17
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaNDA/BLA
Originator CompaniesShanghai Anruite Biomedical Technology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesTonghua Anruite Biopharmaceutical Co LtdShanghai Anruite Biomedical Technology Co Ltd
Inactive CompaniesN/A
Active Indications +[4]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A